Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia Therapy
Researchers from University of Minnesota detail new studies and findings in the area of acute lymphoblastic leukemia therapy
March 16th, 2008
A report, 'Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia,' is newly published data in Journal of Pediatric Hematology. "Adult survivors of childhood acute lymphoblastic leukemia (ALL) have an earlier than expected mortality from cardiovascular disease. This study examined endothelial function in 75 young (age 30.2±7.1 y) adult survivors of childhood ALL who received chemotherapy without cranial radiation (n=25) or chemotherapy combined with cranial radiation (n=50) compared with a healthy control group of similar sex, age, and weight (n=59)," scientists writing in the Journal of Pediatric Hematology report. ...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-16)
|
